en · de · es · fr · pt
cjc-1295-notes.peptides7501.com › Faq › Molecular Background And Naming — Practical Notes

Molecular Background And Naming — Practical Notes

By Editorial Desk · published 2025-11-25 · last reviewed 2026-01-08 · Faq

If you have been reading about Cyclic AMP and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-01-08. Numbers and descriptions here follow the published literature rather than marketing material.

Molecular Background and Naming

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

Background and Naming Conventions

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight (no linker)~3.37 kDaCalculated from peptide sequence
Molecular weight (with linker)~3.65 kDaIncludes albumin-binding moiety
AppearanceWhite to off-white powderTypically lyophilized
SolubilitySoluble in waterAlso dissolves in aqueous buffers
Common synonymsModified GRF(1-29), DAC:GRFUsage varies by source

Receptor Action and Clearance

Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Related pages on this site

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

Receptor Action and Pharmacokinetics

CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.

The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.

Analytical Characterization and Storage

Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.

Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.

Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.

Further detail

In mycology, the term trama is used in two ways. In the broad sense, it is the inner, fleshy portion of a mushroom's basidiocarp, or fruit body. It is distinct from the outer layer of tissue, known as the pileipellis or cuticle, and from the spore-bearing tissue layer known as the hymenium. In essence, the trama is the tissue that is commonly referred to as the "flesh" of mushrooms and similar fungi. The second use is more specific, and refers to the "hymenophoral trama" that supports the hymenium. It is similarly interior, connective tissue, but it is more specifically the central layer of hyphae running from the underside of the mushroom cap to the lamella or gill, upon which the hymenium rests. Various types have been classified by their structure, including trametoid, cantharelloid, boletoid, and agaricoid, with agaricoid the most common by far. In the agarcoid type, the central trama's hyphae usually run parallel to each other, with a clear boundary area called a sub-hymenium followed by the hymenium itself on the outer layer facing the environment. The word "trama" is Latin for the "weft" or "woof" yarns in the weaving of cloth. This is related to the basidiocarp trama being "filler" tissue and that analogously the woof yarn in weaving is sometimes called "fill". Furthermore, the trama tends to be soft tissue, and in weaving, the woof yarn is not tightly stretched; it therefore need not as a rule be as strong as the warp yarn.

Large gatherings of vapers, called vape meets, take place around the US. They focus on e-cigarette devices, accessories, and the lifestyle that accompanies them. Vapefest, which started in 2010, is an annual show hosted by different cities. People attending these meetings are usually enthusiasts that use specialized, community-made products not found in convenience stores or gas stations. These products are mostly available online or in dedicated "vape" storefronts where mainstream e-cigarettes brands from the tobacco industry and larger e-cig manufacturers are not as popular. Some vape shops have a vape bar where patrons can test out different e-liquids and socialize. The Electronic Cigarette Convention in North America which started in 2013, is an annual show where companies and consumers meet up. A subclass of vapers configure their atomizers to produce large amounts of vapor by using low-resistance heating coils. This practice is called "cloud-chasing". By using a coil with very low resistance, the batteries are stressed to a potentially unsafe extent. This could present a risk of dangerous battery failures. As vaping comes under increased scrutiny, some members of the vaping community have voiced their concerns about cloud-chasing, stating the practice gives vapers a bad reputation when doing it in public. The Oxford Dictionaries' word of the year for 2014 was "vape".

=== Cladogram === Below is a phylogenetic tree of the phylum. Lines of the cladogram show evolutionary relationships between the major groups of extinct taxa, which are denoted with a dagger (†), and extant taxa.

Mass spectrometry is an important method for the characterization and sequencing of proteins. The two primary methods for ionization of whole proteins are electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). In keeping with the performance and mass range of available mass spectrometers, two approaches are used for characterizing proteins. In the first, intact proteins are ionized by either of the two techniques described above, and then introduced to a mass analyzer. This approach is referred to as "top-down" strategy of protein analysis. The top-down approach however is largely limited to low-throughput single-protein studies. In the second, proteins are enzymatically digested into smaller peptides using proteases such as trypsin or pepsin, either in solution or in gel after electrophoretic separation. Other proteolytic agents are also used. The collection of peptide products are often separated by chromatography prior to introduction to the mass analyzer. When the characteristic pattern of peptides is used for the identification of the protein the method is called peptide mass fingerprinting (PMF), if the identification is performed using the sequence data determined in tandem MS analysis it is called de novo peptide sequencing. These procedures of protein analysis are also referred to as the "bottom-up" approach, and have also been used to analyse the distribution and position of post-translational modifications such as phosphorylation on proteins.

Sources: en.wikipedia.org

Supporting material

==== Pandemic unemployment fraud and debt ==== In January 2021, the Los Angeles Times reported that Newsom's administration had mismanaged $11.4 billion by disbursing unemployment benefits to ineligible claimants, especially those paid through the federally funded Pandemic Unemployment Assistance program. Another $19 billion in claims remained under investigation for fraud. At the same time, legitimate claimants faced lengthy delays in receiving benefits. The state's unemployment system had been overseen by California Labor Secretary Julie Su, a Newsom appointee, whom President Joe Biden later appointed as deputy secretary of labor in February 2021. Political opponents attributed the crisis to the Newsom administration's failure to heed multiple warnings by federal officials of the potential for fraud, while Newsom's administration said the Trump administration's failure to provide appropriate guidance for the new federally funded program contributed to the fraud. Experts said much of the fraud appeared to originate from international criminal gangs in 20 countries. A report by California State Auditor Elaine Howle said $810 million was disbursed to claimants who had fraudulently filed on behalf of inmates in the state's prison system. According to The Sacramento Bee, by the summer of 2021, California owed $23 billion to the federal government for unemployment benefits paid out during the pandemic, which was 43% of all unemployment debt, owed by 13 states at the time, to the federal government.

Hong Kong International Airport is the territory's primary airport, replacing Kai Tak International Airport which ended operations in 1998. Over 100 airlines operate flights from the airport, including Cathay Pacific, the flag carrier of Hong Kong. It has been regarded as a 5-star airline by Skytrax and has been in the world's top 10 list of airlines for multiple consecutive years. Hong Kong Airlines, low-cost airline HK Express, low-cost airline Greater Bay Airlines, and cargo airline Air Hong Kong are all airlines based in Hong Kong. Hong Kong International Airport was the eighth-busiest airport by passenger traffic pre-COVID and handles the most air-cargo traffic in the world. Most private recreational aviation in Hong Kong, flies through Shek Kong Airfield, under the supervision of the Hong Kong Aviation Club.

Acetylpropionylmorphine is an opioid analog that is an ester of morphine. It was developed in the early 1900s after first being synthesized in United Kingdom in 1875 but shelved along with heroin and various other esters of morphine. Acetylpropionylmorphone was never used medically, instead being widely sold as one of the first "designer drugs" for around five years following the introduction of the first international restrictions on the sale of heroin in 1925. It is described as being virtually identical to heroin and morphine in its effects, and consequently was itself banned internationally in 1930 by the Health Committee of the League of Nations, in order to prevent its sale as an unscheduled alternative to heroin.

March 5 Trump appoints DHS Secretary Noem as the "Special Envoy for The Shield of the Americas," a security initiative focusing on the Western Hemisphere. Trump nominates U.S. Senator Markwayne Mullin to replace Noem as DHS Secretary. The Pentagon officially designates artificial intelligence company Anthropic a supply chain risk – the first time the government has given this label to a domestic firm. Anthropic states it will challenge the decision in court. March 6 – Virginia passes legislation to prohibit schools from teaching about falsehoods of the January 6 United States Capitol attack. March 7 – Trump hosts the first Shield of the Americas summit in Doral, Florida, with 12 Latin American countries in attendance. Mach 10 – U.S. federal judge Sarah D. Morrison rules that the prediction market Kalshi constitutes as gambling and must adhere to state gambling regulations. March 11 – 2026 Minab school attack: A preliminary inquiry finds that the U.S. is at fault for an airstrike which killed 168–180 people at a girls' only elementary school in Minab, Iran. March 12 Temple Israel synagogue attack: A suspected attacker is killed after a vehicle rams into a synagogue in West Bloomfield, Michigan, and travels "with purpose down the hall of the building". 2026 Old Dominion University shooting: A former National Guardsman opens fire at an ROTC class at Old Dominion University in Norfolk, Virginia, killing the instructor and injuring two cadets. Cadets subdue the shooter, with one fatally stabbing him.

== Hydrogen-5 == 5H (atomic mass 5.03531(10) Da), with one proton and four neutrons, is highly unstable. It has been synthesized in the lab by bombarding tritium with fast-moving tritons; one triton captures two neutrons from the other, becoming a nucleus with one proton and four neutrons. The remaining proton may be detected, and the existence of 5H deduced. It decays by double neutron emission into 3H and has a half-life of 86(6) ys (8.6(6)×10−23 s) – the shortest half-life of any known nuclide.

Sources: en.wikipedia.org

Notes from published material

Irène Joliot-Curie (Physics, 1935) Julian Schwinger (Physics, 1965) Pyotr Kapitsa (Physics, 1978) Frank Wilczek (Physics, 2004) Michael Kremer (Economics, 2009) Jack Szostak (Physiology or Medicine, 2009) Robert Lefkowitz (Chemistry, 2012) Victor Ambros (Physiology or Medicine, 2024, obtained Polish citizenship in 2026) John Hopfield (Physics, 2024)

=== Built under license === Focke-Wulf C.19 – license-built (autogyro)– licence-built version of the Cierva C.19, with Siemens Sh 14 engine. (one prototype, converted from Cierva C.19 Mk.IV) Focke-Wulf C.30 Heuschrecke (Grasshopper) – licence-built version of the Cierva C.30, with Siemens Sh 14 engine. Focke-Wulf FWP.149D – license-built Piaggio P.149

DCPIP can also be used as an indicator for vitamin C. If vitamin C, which is a good reducing agent, is present, the blue dye, which turns pink in acidic conditions, is reduced to a colorless compound by ascorbic acid. This reaction is a redox reaction: vitamin C (ascorbic acid) is oxidized to dehydroascorbic acid, and DCPIP is reduced to the colorless compound DCPIPH2

== Uses == NMF is a specialized solvent in oil refineries. It is a precursor in specialized amidation reactions where formamide would not be suitable. These reactions can generally be categorized by the following equation:

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Why do two versions share one name?

Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.

What is the relationship to GRF(1-29)?

The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.

Does this compound occur naturally in the body?

No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.

Network